2017 IOTA Congress - IOTA classifications of benign masses

IOTA 2017 Congress International Ovarian Tumor Analysis Belgium

Dr. Wouter Froyman
What happens to conservatively managed masses classified as benign using IOTA rules and models?
Interim analysis of the IOTA 5 trial with one year follow up.

 

các bài viết khác